Detailed Information on Publication Record
2016
Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance
MEBAZAA, A., H. TOLPPANEN, C. MUELLER, J. LASSUS, S. DISOMMA et. al.Basic information
Original name
Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance
Authors
MEBAZAA, A. (250 France), H. TOLPPANEN (246 Finland), C. MUELLER (756 Switzerland), J. LASSUS (246 Finland), S. DISOMMA (380 Italy), G. BAKSYTE (440 Lithuania), M. CECCONI (826 United Kingdom of Great Britain and Northern Ireland), D.J. CHOI (410 Republic of Korea), A.C. SOLAL (250 France), M. CHRIST (276 Germany), J. MASIP (724 Spain), M. ARRIGO (250 France), S. NOUIRA (788 Tunisia), D. OJJI (566 Nigeria), F. PEACOCK (840 United States of America), M. RICHARDS (554 New Zealand), N. SATO (392 Japan), K. SLIWA (710 South Africa), Jindřich ŠPINAR (203 Czech Republic, guarantor, belonging to the institution), H. THIELE (276 Germany), M.B. YILMAZ (792 Turkey) and J. JANUZZI (840 United States of America)
Edition
Intensive care medicine, NEW YORK, SPRINGER, 2016, 0342-4642
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30201 Cardiac and Cardiovascular systems
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 12.015
RIV identification code
RIV/00216224:14110/16:00090652
Organization unit
Faculty of Medicine
UT WoS
000368722000002
Keywords in English
Heart failure; Cardiogenic shock; Emergency; Treatment
Tags
Tags
International impact, Reviewed
Změněno: 29/8/2016 16:51, Soňa Böhmová
Abstract
V originále
Purpose: Acute heart failure (AHF) causes high burden of mortality, morbidity, and repeated hospitalizations worldwide. This guidance paper describes the tailored treatment approaches of different clinical scenarios of AHF and CS, focusing on the needs of professionals working in intensive care settings. Results: Tissue congestion and hypoperfusion are the two leading mechanisms of end-organ injury and dysfunction, which are associated with worse outcome in AHF. Diagnosis of AHF is based on clinical assessment, measurement of natriuretic peptides, and imaging modalities. Simultaneously, emphasis should be given in rapidly identifying the underlying trigger of AHF and assessing severity of AHF, as well as in recognizing end-organ injuries. Early initiation of effective treatment is associated with superior outcomes. Oxygen, diuretics, and vasodilators are the key therapies for the initial treatment of AHF. In case of respiratory distress, non-invasive ventilation with pressure support should be promptly started. In patients with severe forms of AHF with cardiogenic shock (CS), inotropes are recommended to achieve hemodynamic stability and restore tissue perfusion. In refractory CS, when hemodynamic stabilization is not achieved, the use of mechanical support with assist devices should be considered early, before the development of irreversible end-organ injuries. Conclusion: A multidisciplinary approach along the entire patient journey from pre-hospital care to hospital discharge is needed to ensure early recognition, risk stratification, and the benefit of available therapies. Medical management should be planned according to the underlying mechanisms of various clinical scenarios of AHF.